Abstract
Introduction: Non communicable diseases these days are causing a havoc in the overall development of humanity. Of all non-communicable diseases, Diabetes Mellitus is playing a notorious role in the devastating phase of public health.. Ayurveda, the life science provides astonishing results in such life style disorders. Vriddhadaru an excellent Ayurvedic drug and Ipomoea pes-caprae has been traditionally used as Vriddhadaru, efective in diabetic management with promising results. But, the anti-diabetic effect of the drug has not been scientifically appreciated. This study ascertains the hypoglycaemic effect of the drug in a pre-clinical model.
Methodology: In the present study, alloxan induced 18 diabetic albino rabbits were divided into 3 groups with 6 rabbits in each group. On the day of experiment, after assessing the fasting blood
sugar levels in all 18 rabbits, root powder of the test drug as CMC suspension in the dose of 0.56 g/kg body weight and the standard drug, metformin; in the dose of 0.024 mg/kg body weight were administered to the first group and second group respectively. The third group was kept as control and administered with distilled water alone. Later, the blood glucose values were taken at 1st, 3rd and 5th hour and the obtained values were compared with in the group and between the groups.
Observations and Results: The blood glucose levels were compared using paired t test for within the group analysis and by student t test for between the group analysis. Within the group comparison of blood sugar level in group 1 showed significant decrease in the level at 1 hour, 3rd hour and 5th hour from the corresponding fasting blood sugar levels. In group 2, significant decrease of blood sugar level was seen between fasting blood sugar level and 1 hour value and also in fasting blood sugar value and 5th hour value. Between group comparison of group 1 and group 2 showed no significant difference in the change of the blood sugar level at different time intervals
Discussion: Ayurvedic literature proposes Pramehaghna property to the drug Vriddhadaru which is substantiated through this pre-clinical trial. Further, hypoglycaemic action of Ipomoea pescaprae
(Linn.) R. Br. is mainly attributable to the chemical constituents which have proven antioxidant and α-glucosidase inhibitory activity.
Conclusion: From the above study, it is inferred that Ipomoea pes-caprae (Linn.) R. Br. is equally effective in reducing blood sugar levels in Alloxan induced diabetic rabbits against the standard drug Metformin.